Skip to main content
Drimble Texas

Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics

Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics

ZURICH, Oct 13 (Reuters) -- Swiss drugmaker Roche entered a licensing agreement worth up to $1.16 billion with Rona Therapeutics for its investigational obesity drug candidate, the…

More from Gulf Coast